Infliximab and adalimumab, unlike ustekinumab, increase serum KL‐6 levels in Japanese patients with psoriasis

E-ISSN： 1346-8138|42|8|828-829

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.42, Iss.8, 2015-08, pp. : 828-829

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab‐treated patients with psoriasis in a clinical‐practice setting

BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. : 855-857

John Wiley & Sons Inc

Access to resources Recommend Favorite

The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab‐treated patients with psoriasis in a clinical‐practice setting

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. : 855-857

John Wiley & Sons Inc

Access to resources Recommend Favorite

Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 8, 2015-08 ,pp. : 1576-1581

John Wiley & Sons Inc

Access to resources Recommend Favorite

Usefulness of the Serum KL-6 Assay in Patients with Hepatitis C Virus

Intervirology, Vol. 48, Iss. 6, 2005-07 ,pp. : 400-404

Karger

Access to resources Recommend Favorite

Paradoxical ulcerative colitis during adalimumab treatment of psoriasis resolved by switch to ustekinumab

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 551-555

John Wiley & Sons Inc

Access to resources Recommend Favorite